Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 12
- 0 vs. Q2 2024
- Portfolio value
- $24.2M
- +$4.43M (+22.5%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | COM | 5,113,348 | $14.6M | 60.3% | 00.0% | Unchanged | History |
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $6.40M | 26.5% | 00.0% | Unchanged | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 2,867 | $1.64M | 6.8% | +998+53.4% | Added | History |
| BRK.BBerkshire Hathaway Inc | Stock | 1,151 | $529.6K | 2.2% | +126+12.3% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 10,941 | $278.7K | 1.2% | +10,941 | New | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 34,073 | $193.9K | 0.8% | +3,690+12.1% | Added | History |
| LXEOLexeo Therapeutics, Inc. | COM | 17,851 | $161.4K | 0.7% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 11,365 | $130.9K | 0.5% | −2,535−18.2% | Reduced | History |
| KYTXKyverna Therapeutics, Inc. | COM | 22,981 | $112.4K | 0.5% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 43,465 | $80.0K | 0.3% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 18,403 | $36.1K | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 17,488 | $25.2K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (1)
Positions held at the end of Q2 2024 that are gone from this filing.